Paula Monteiro
Overview
Explore the profile of Paula Monteiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almeida-Nunes D, Nunes M, Osorio H, Ferreira V, Lobo C, Monteiro P, et al.
Biochem Biophys Rep
. 2024 Jul;
39:101755.
PMID: 38974022
Ovarian cancer (OC) patients develop ascites, an accumulation of ascitic fluid in the peritoneal cavity anda sign of tumour dissemination within the peritoneal cavity. This body fluid is under-researched, mainly...
2.
Salta S, Sequeira J, Lobo J, Sousa A, Sousa H, Baldaque I, et al.
J Infect Public Health
. 2024 May;
17(6):1057-1064.
PMID: 38705058
Background: Cervical cancer screening remains an essential preventive tool worldwide. First line high-risk Human Papillomavirus (HrHPV) genotyping became gold standard for cervical cancer screening, and has been adopted by several...
3.
Barreto I, Oliveira F, Monteiro P
Open Respir Arch
. 2023 Jul;
5(2):100225.
PMID: 37496872
No abstract available.
4.
Joao D, Cardoso S, Monteiro P, Leal C, Bartosch C
Virchows Arch
. 2023 Jun;
483(4):549-554.
PMID: 37369928
Despite all precautions in pathology laboratories, contaminations and specimen mix-ups still occur and can negatively impact both patients and institutions. We present two cases in which short tandem repeat (STR)...
5.
Rosario A, Sousa A, Varandas T, Marinho-Dias J, Medeiros R, Martins G, et al.
J Med Virol
. 2023 May;
95(5):e28762.
PMID: 37212334
The vaginal microbiome has emerged as potentially influencing the natural history of Human Papillomavirus (HPV) infections and their clinical impact. We aimed to characterize the vaginal microbiome in samples from...
6.
Lobo J, Lobo C, Leca L, Rodrigues A, Henrique R, Monteiro P
Pathobiology
. 2022 Dec;
90(4):233-240.
PMID: 36574757
Introduction: The Paris classification highlights the need to focus on accurately identifying high-grade urothelial carcinoma (HGUC). Herein, we aimed to assess the overall implementation and diagnostic performance of the Paris...
7.
Rosario A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leca L, et al.
J Med Virol
. 2022 Dec;
95(1):e28414.
PMID: 36541747
Cervical cancer prevention is based on primary prevention with vaccines against Human Papillomavirus (HPV) and secondary prevention by screening with High-Risk-HPV (Hr-HPV) detection. Since 2017, cervical cancer screening in women...
8.
Martins J, Carvalho C, Freitas F, Monteiro P
Port J Card Thorac Vasc Surg
. 2022 Jul;
29(2):85.
PMID: 35780405
Laryngotracheobronchial papillomatosis is a rare dis- ease, with few reported cases. Histologically has been report- ed has a benign proliferation of the epithelium, limited to the larynx but it may...
9.
Martins J, Carvalho C, Freitas F, Monteiro P
Port J Card Thorac Vasc Surg
. 2022 Apr;
29(1):83.
PMID: 35471210
Videobronchofibroscopy of a Chinese 74-year-old woman showing abundant whitish plaques in the vocal cords with antraconic lesions extending throughout the tracheal pathway and bronchial trees, predominantly in the upper left...
10.
Salta S, Maia-Moco L, Estevao-Pereira H, Sequeira J, Vieira R, Bartosch C, et al.
Int J Cancer
. 2021 Aug;
149(11):1916-1925.
PMID: 34460099
Cervical cancer remains a health concern. Effective screening programs are critical to reduce the incidence and mortality. High-risk HPV (hr-HPV) testing as primary screening tool discloses high sensitivity but suboptimal...